TORONTO, April 15, 2019 /CNW/ - Carrot Rewards, Canada's most popular wellness rewards app and AI-driven engagement platform announced today it will launch an innovative new campaign in collaboration with The Lung Association – Ontario and Boehringer Ingelheim (Canada) Ltd., to reach patients with chronic obstructive pulmonary disease (COPD).
The program will educate Carrot users about the symptoms of COPD, and target Canadians on the platform who have been diagnosed with COPD; helping to inform them about how to mitigate symptoms through lifestyle changes and potential medical alternatives, as well as direct them to the best available resources.
"Our research indicates that more awareness around COPD, including its risk factors and symptoms, is a gap that needs to be filled. Easy-to-use tools like Carrot Rewards can help patients and their caregivers close that awareness gap and lead to more meaningful conversations with their healthcare providers – and that means better breathing" said George Habib, President & CEO, The Lung Association - Ontario.
Carrot Rewards has already awarded Canadians two billion points from everyday reward programs like Aeroplan®, SCENE®, Petro-Points™, More Rewards®, Drop and RBC Rewards™ for participating in fun educational quizzes and meeting daily step goals. Now, Carrot users will be rewarded for learning about COPD and have access to resources in Ontario.
"Giving patients a new and innovative tool to learn about COPD and how they can better manage their disease is helping to fill an educational gap in this area. This new partnership with Carrot Rewards will help empower those living with COPD to lead a healthy life and potentially minimize their symptoms like breathlessness" said Dr. Tony D'Urzo, Associate Director, Health Science Research Component, Faculty of Medicine, University of Toronto.
This industry partnership is a first-of-its kind for Carrot Rewards, and another way the platform is helping to encourage the over one million Canadian users to make positive changes for themselves and their families.
"We are committed to finding innovative solutions that will help patients live better lives," said Richard Mole, President and CEO, Boehringer Ingelheim (Canada) Ltd. "This latest collaboration with the Lung Association and Carrot Rewards will not only help educate Canadians with COPD, but will give them a convenient way to manage their condition - right at their fingertips."
About Carrot Rewards Carrot Rewards is an AI-driven wellness app and brand engagement platform that leverages behavioural economics and nudge theory to motivate and reward users for making better lifestyle choices. Carrot maximizes appeal and engagement by offering users a choice of rewards from the most popular consumer loyalty programs — in Canada, users can earn Aeroplan® Miles, SCENE® points, Petro-Points™, More Rewards® points, Drop points or RBC Rewards — each time they interact with the app.
With well over one million users in this country, Carrot was recognized as Canadian App of the Year by MobileSyrup, ranked by Bond Brand Loyalty as a Top 10 Canadian Loyalty Program in The Loyalty Report 2018, named one of the Top Fastest Growing Companies by Canadian Business and Maclean's Magazine and was the most recent Global Innovation Award winner at the World Government Summit.
The Carrot Rewards platform was created in collaboration with Canadian government agencies, health NGOs and the private sector.
For more information, please visit: www.carrotapp.com Twitter & Instagram: @carrot_rewards Facebook: /carrotrewards
About The Lung Association – Ontario The Lung Association – Ontario is a not-for-profit organization dedicated to helping all Ontarians breathe. Our community of donors, patients, researchers, volunteers and professional staff work to ensure Ontarians have healthy lungs, bodies and clean air necessary to breathe. We achieve this by promoting healthy breathing, supporting those living with lung disease and finding future solutions. All of this is done with the goal of delivering a future of better breathing for all.
Boehringer Ingelheim (Canada) Ltd. Improving the health and quality of life of patients is the goal of Boehringer Ingelheim, a research-driven pharmaceutical company. In doing so, the focus is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients' lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
Family-owned since it was established in 1885, Boehringer Ingelheim is one of the top 20 companies in the pharmaceutical industry. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2017, Boehringer Ingelheim achieved net sales of nearly 18.1 billion euros. Research and development expenditure, exceeding three billion euros, corresponded to 17.0 per cent of net sales.
As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment.
The Canadian headquarters of Boehringer Ingelheim was established in 1972 in Montreal, Quebec and is now located in Burlington, Ontario. Boehringer Ingelheim employs approximately 600 people across Canada.
Available for Interviews: Andreas Souvaliotis, CEO and Founder, Carrot Rewards George Habib, President and CEO, The Lung Association - Ontario Richard Mole, President and CEO, Boehringer Ingelheim (Canada) Ltd.
SOURCE Carrot Rewards
For further information: For media inquiries please contact: Duet Public Relations, Jennifer Love | 416-271-5477, [email protected]; Boehringer Ingelheim (Canada) Ltd., Jennifer Mota | 905-631-4739, [email protected]